1,721,002 research outputs found

    Initial Reference Values of Electrocardiographic Alternans by Enhanced Adaptive Matched Filter

    No full text
    Electrocardiographic alternans (ECGA) is the ABAB fluctuation of the electrocardiogram (ECG) and may manifest as P-wave/QRS-complex/T-wave alternans (PWA/QRSA/TWA). ECGA is a cardiovascular risk index, and its characterization may depend on the automatic identification method. Normal ranges (needed to define risk conditions) are still not available for the new enhanced adaptive matched filter (EAMF) method. Thus, the present study aims to provide them. EAMF was used to characterize ECGA (in terms of: amplitude, μ V; area, μ V× ms; and duration, number of beats) in 15-lead ECG from 52 healthy subjects (39/13 male/female), from the 'PTB Diagnostic ECG Database'. Median ECGA values over leads and subjects were: 2μ V, 200μ V× ms, and 17 beats for PWA; 1 μ V, 80 μ V× ms, and 8 beats for QRSA; and 7 μ V, 1300μ V× ms, and 49 beats for TWA. ECGA in females (PWA:4 μ V, 350 μ V× ms, and 22 beats; QRSA: 1 μ V, 80 μ V × ms, and 11 beats; TWA: 10 μ V; 2000 μ V× ms, and 49 beats) was higher (∗p < 0.05) than ECGA in males (PWA: 20 μ V∗, 200 μ V× ms∗, and 16 beats∗ QRSA: 1 μ V, 80 μ V× ms, and 7 beats; TWA: 6μ V, 1150 μ V× ms, and 48 beats). Maximum ECGA values were observed in fundamental leads. The observed reference ECGA values seem reliable if comparing with pathological populations but are initial and analysis of wider datasets is needed

    Classification of drug-induced hERG potassium-channel block from electrocardiographic T-wave features using artificial neural networks

    Full text link
    Background: Human ether‐à‐go‐go‐related gene (hERG) potassium‐channel block represents a harmful side effect of drug therapy that may cause torsade de pointes (TdP). Analysis of ventricular repolarization through electrocardiographic T‐wave features represents a noninvasive way to accurately evaluate the TdP risk in drug‐safety studies. This study proposes an artificial neural network (ANN) for noninvasive electrocardiography‐ based classification of the hERG potassium‐channel block. Methods: The data were taken from the “ECG Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects” Physionet database; they consisted of median vector magnitude (VM) beats of 22 healthy subjects receiving a single 500 μg dose of dofetilide. Fourteen VM beats were considered for each subject, relative to time‐points ranging from 0.5 hr before to 14.0 hr after dofetilide administration. For each VM, changes in two indexes accounting for the early and the late phases of repolarization, ΔERD30% and ΔTS/A, respectively, were computed as difference between values at each postdose time‐point and the predose time‐point. Thus, the dataset contained 286 ΔERD30%‐ΔTS/A pairs, partitioned into training, validation, and test sets (114, 29, and 143 pairs, respectively) and used as inputs of a two‐layer feedforward ANN with two target classes: high block (HB) and low block (LB). Optimal ANN (OANN) was identified using the training and validation sets and tested on the test set. Results: Test set area under the receiver operating characteristic was 0.91; sensitivity, specificity, accuracy, and precision were 0.93, 0.83, 0.92, and 0.96, respectively. Conclusion: OANN represents a reliable tool for noninvasive assessment of the hERG potassium‐channel block

    Neonatal Clinical Outcomes: a Comparative Analysis

    No full text
    The most popular neonatal clinical outcomes, which are blood pH (PH), base excess (BE) and Apgar after 5 minutes from birth (AP5), may provide contrasting information. Thus, aim of the paper is to perform a critical evaluation and comparison of PH, BE and AP5. Reliability of neonatal clinical outcomes was evaluated in relation to perinatal features. Neonatal and fetal cardiotocographic data of 391 newborns (CTU-CHB Intrapartum Cardiotocography Database) were analyzed. Newborns were classified as positive (i.e., as showing critical conditions) if PH&lt;7.10 or BE&lt;-10mmol/l or AP5&lt;7, as negative (i.e., as showing healthy conditions) otherwise. Agreement between pairs of neonatal clinical outcomes was evaluated by computing the correlation coefficient. Fetal decelerations were characterized in terms of rate of occurrence, depth, mean, duration, and area. Correlation between PH and BE, PH and AP5 and BE and AP5 was 0.83, 0.45 and 0.38 (P&lt;0.01), respectively; 329 newborns (84%) were equally classified by all neonatal clinical outcomes, 5 as positive and 324 as negative. Deceleration depth and rate of occurrence were comparable among positive/negative classes, while deceleration mean, duration and area were systematically higher in the positive than in the negative classes, also statistically only for PH classification. Positive class by PH counted the highest number of small newborns; large newborns were similarly distributed over all positive classes. Objective neonatal clinical outcomes, and in particular PH, seems to be more reliable than subjective clinical outcomes, and thus should be preferable for describing neonatal health status

    Cardiorespiratory DB: Collection of cardiorespiratory data acquired during normal breathing, deep breathing and breath holding

    Full text link
    The database is constituted by 50 datasets containing cardiorespiratory signals acquired from 50 healthy volunteer subjects (one dataset for each subject; 23 males and 27 females; age: 23±5 years) while performing normal breathing, deep breathing, and breath holding, and two spreadsheet files, namely the “SubjectsInfo.xlsx” and “DBInfo.xlsx” containing the metadata of subjects (including demographic data) and of acquired signals, respectively. Cardiorespiratory signals consisted in simultaneously recorded 12-lead electrocardiograms acquired by the clinical M12 Global InstrumentationR digital Holter ECG recorder, and single-lead electrocardiograms and respiration signals acquired by the wearable chest strap BioHarness 3.0 by Zephyr. The database may be useful to: (1) validate the use of wearable sensors in the acquisition of cardiorespiratory data during different respiration kinds, including apnea; (2) investigate the physiological association between cardiovascular and respiratory systems; (3) validate algorithms able to indirectly extract the respiration signal from the electrocardiogram; (4) study the fatigue level induced by a series of controlled respiration patterns; and (5) investigate the effect of COVID-19 infection on the cardiorespiratory system

    Review on Cardiorespiratory Complications after SARS-CoV-2 Infection in Young Adult Healthy Athletes

    Full text link
    This review analyzes scientific data published in the first two years of the COVID-19 pandemic with the aim to report the cardiorespiratory complications observed after SARS-CoV-2 infection in young adult healthy athletes. Fifteen studies were selected using PRISMA guidelines. A total of 4725 athletes (3438 males and 1287 females) practicing 19 sports categories were included in the study. Information about symptoms was released by 4379 (93%) athletes; of them, 1433 (33%) declared to be asymptomatic, whereas the remaining 2946 (67%) reported the occurrence of symptoms with mild (1315; 45%), moderate (821; 28%), severe (1; 0%) and unknown (809; 27%) severity. The most common symptoms were anosmia (33%), ageusia (32%) and headache (30%). Cardiac magnetic resonance identified the largest number of cardiorespiratory abnormalities (15.7%). Among the confirmed inflammations, myocarditis was the most common (0.5%). In conclusion, the low degree of symptom severity and the low rate of cardiac abnormalities suggest that the risk of significant cardiorespiratory involvement after SARS-CoV-2 infection in young adult athletes is likely low; however, the long-term physiologic effects of SARS-CoV-2 infection are not established yet. Extensive cardiorespiratory screening seems excessive in most cases, and classical pre-participation cardiovascular screening may be sufficient

    Model-Based Estimation of Electrocardiographic QT Interval from Phonocardiographic Heart Sounds in Healthy Subjects

    Full text link
    The electrocardiographic QT interval is an index of cardiac risk commonly used in clinics. Accurate QT measure is challenging, especially in noisy conditions, when acquisitions of phonocardiograms (PCGs) may be more reliable than acquisitions of electrocardiograms (ECGs). However, PCG features are less used in clinics. Thus, aim of the study was to propose a model for indirectly measuring the electrocardiographic QT interval from the phonocardiographic heart sounds in healthy subjects. To this aim, simultaneously acquired PCGs and ECGs of 99 healthy subjects were processed to obtain median PCG and ECG beats. Beat length, S1 onset and S2 onset were identified from the median PCG beat, while QT interval (QT) was measured from the median ECG beat. Then, a regression model was formulated by regression analysis to obtain PCG-based QT estimation (QT) and validated by leave-one-out cross-validation. Correlation coefficient (p) and estimation error were also computed. QT and QT did not differ significantly (model formulation: 362ms vs 358ms; model validation:360ms vs 358ms, respectively; P>0.5) and were significantly correlated (model formulation: p=0.7, p<10-13; model validation: p=0.6, P<10-10); median error is 1 ms (<0.5 in %). Thus, the proposed model provides a reliable estimation of QT interval from PCG heart sounds in healthy subjects

    Annotation dataset of the cardiotocographic recordings constituting the “CTU-CHB intra-partum CTG database”

    No full text
    The proposed dataset provides annotations for the 552 cardiotocographic (CTG) recordings included in the publicly available “CTU-CHB intra-partum CTG database” from Physionet (https://physionet.org/content/ctu-uhb-ctgdb/1.0.0/). Each CTG recording is composed by two simultaneously acquired signals: i) the fetal heart rate (FHR) and ii) the maternal tocogram (representing uterine activity). Annotations consist in the detection of starting and ending points of specific CTG events on both FHR signal and maternal tocogram. Annotated events for the FHR signal are the bradycardia, tachycardia, acceleration and deceleration episodes. Annotated events for the maternal tocogram are the uterine contractions. The dataset also reports classification of each deceleration as early, late, variable or prolonged, in relation to the presence of a uterine contraction. Annotations were obtained by an expert gynecologist with the support of CTG Analyzer, a dedicated software application for automatic analysis of digital CTG recordings. These annotations can be useful in the development, testing and comparison of algorithms for the automatic analysis of digital CTG recordings, which can make CTG interpretation more objective and independent from clinician's experience

    Bradycardia Assessment in Preterm Infants

    No full text
    Prematurity is a severe condition, usually correlated with critical outcomes. One of the major diseases in preterm infants is bradycardia, defined as the heart rate decreasing under 100 bpm for at least two heartbeats in duration. Usually, bradycardia is considered as a manifestation of immature cardiorespiratory control, but no studies investigated its nature in relation to the different clinical features of preterm infants. Thus, aim of this work is to assess the relation between bradycardia features and the main preterm infant clinical features, weight and gestational age. Ten preterm infants were considered, classified according with three criteria: the weight classification, the gestational age classification and the birth size assessment (that combined the two previous classifications). For each preterm infant, bradycardias are automatically identified and characterized in term of bradycardia features: amplitude, duration and area. Moreover, bradycardia events are classified according with their severity. Finally, bradycardia feature distributions of classes that belong to the same classification criterion were compared. Results seems suggesting that bradycardia features differences are more relevant in preterm infants with different weights than in those with different gestational age, contrary to what expected. Anyway, the best results in term of classification were obtained in the birth size assessment; thus, a combined approach that considers both weight and gestational age is preferable. Moreover, a combined evaluation of amplitude and duration for bradycardia characterization can better assess the severity of this arrhythmia and of the preterm infant clinical status

    Cardiac Electrical Alternans in Pregnancy: An Observational Study

    No full text
    In pregnancy, if the woman has a cardiovascular disease, her fetus has an increased risk of inherited cardiac genetic disorders. Aim of this study was to evaluate electrocardiographic alternans (ECGA, mu V) of 23 pregnant women, comparing 12 mothers of fetuses with normal rhythm (MumNRF) and 11 mothers of arrhythmic fetuses (MumArrF). ECGA is a noninvasive cardiac electrical risk marker able to reveal heart electrical instability. ECGA manifests in the ECG as P-wave alternans (PWA), QRS alternans (QRSA) and/or T-wave alternans (TWA). Analysis was performed by the enhanced adaptive matched filter method. ECGA distributions were expressed as: median (interquartile range). Comparisons were performed by the Wilcoxon rank-sum test. Although showing similar heart rate (MumNRF: 85 (19) bpm; MumArrF: 90 (13) bpm), ECGA was higher in MumArrF population than MumNRF one (PWA: 9 (7) mu V vs. 14 (14) mu V; QRSA: 9 (10) mu V vs. 17 (16) mu V, TWA: 12 (14) mu Vvs. 28(17) mu V), but only TWA distributions were statistically different. Moreover, TWA was higher than in a female healthy population (on average 18mu V)in 70% of MumArrF, vs. 33% of MumNRF. Thus, higher TWA in our MumArrF seems to reflect a more unstable heart electrical condition of arrhythmic fetuses' mothers than normal-rhythm fetuses' mothers

    Spectral F-wave index for automatic identification of atrial fibrillation in very short electrocardiograms

    Full text link
    Micro as well as clinical atrial fibrillation (AF) is associated with both F-wave occurrence and high heart-rate variability (HRV). Automatic AF identification typically relies on HRV evaluation only. However, high HRV is not AF specific and may not be reliably estimated in very short electrocardiograms (ECG). This study presents a new algorithm for automatic AF identification in very short ECG based on computation of a new spectral F-wave index (SFWI). Data consisted of short (9 heartbeats) 12-lead ECG acquired from 6628 subjects divided in assessment dataset and validation dataset. Each lead was independently analyzed so that 12 values of SFWI, indicating the percentage of spectral power in the 4–10 Hz band, were obtained for each ECG. Additionally, a global SFWI value was computed as the median of SFWI distribution over leads. To identify AF, a threshold on SFWI was firstly assessed on the assessment dataset, and then evaluated on the validation dataset by computation of sensitivity (SE), specificity (SP) and accuracy (AC). Results were compared with those of standard HRV-based approaches. AF identification by SFWI was already good when considering a single lead (SE: 84.6%–88.8%, SP: 84.5%–87.0%, AC: 84.5%–87.3%), improved significantly when combining the 12 leads (SE: 89.0%, SP: 87.0%, AC: 88.7%) and, overall, performed better than standard HRV-based approaches (SE: 82.2%, SP: 83.6%, AC: 83.4%). The presented algorithm is a useful tool to automatically identify AF in very short ECG, and thus has the potentiality to be applied for detection of both micro and clinical AF
    corecore